RENOVORX INC

RNXT · NASDAQ

Updated at 2026-10-15 06:51:57

$1.12-2.6%
Today's High
$1.15
Today’s Low
$1.09
RENOVORX INC (RNXT) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.13
Previous Close
$1.12
Volume
624.37K
Market Cap
$50.54M
P/E Ratio
--
EPS
$-0.31

Previous Day Range

$1.09$1.15

52-Week Range

$0.70$2.59

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
2570 WEST EL CAMINO REAL, MOUNTAIN VIEW, CA, UNITED STATES, 94040
Country
US
Listing Date
2021-08-17
Fiscal Year End
December
Shares Outstanding
45.05M
CIK
0001574094

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. The company is headquartered in Los Altos, California.

Financial Metrics

Revenue

2026-06-30

$909K

2026-03-31

$563K

2025-12-31

$238K

2025-09-30

$266K

Operating Expenses

2026-06-30

$3.97M

2026-03-31

$3.94M

2025-12-31

$3.73M

2025-09-30

$3.41M

Net Income

2026-06-30

-$2.91M

2026-03-31

-$3.52M

2025-12-31

-$2.94M

2025-09-30

-$2.91M

Net Profit Margin

2026-06-30

-320.24%

2026-03-31

-625.4%

2025-12-31

-1.23K%

2025-09-30

-1.09K%

Earnings Per Share

2026-06-30

$-0.05

2026-03-31

$-0.08

2025-12-31

$-0.08

2025-09-30

$-0.08

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$2.9M

2026-03-31

-$3.52M

2025-12-31

-$2.94M

2025-09-30

-$2.91M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.